🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,85 USD

Máx. histórico

185,50

96 días

Caída desde máximo

-11,13%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+13,42%

Cierre anterior

145,35

Rango de hoy

157,91 – 169,53

Volumen hoy

4.056.105

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,31%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,46 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
206,79 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 14 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/11/1997 9,38 9,50 8,88 9,00 -2,70% 6,67% 192.000
06/11/1997 9,75 9,75 9,25 9,25 -3,27% 5,13% 83.000
05/11/1997 9,63 9,63 9,50 9,56 +0,00% 1,30% 36.300
04/11/1997 9,63 9,75 9,38 9,56 -1,92% 3,90% 65.200
03/11/1997 10,00 10,00 9,63 9,75 +2,63% 3,75% 66.900
31/10/1997 9,94 10,13 9,38 9,50 +2,70% 7,55% 52.100
30/10/1997 9,50 9,75 9,25 9,25 -4,52% 5,26% 32.800
29/10/1997 10,25 10,25 9,50 9,69 -0,64% 7,32% 54.100
28/10/1997 8,00 10,25 7,88 9,75 +14,71% 29,69% 154.100
27/10/1997 10,13 10,50 8,50 8,50 -19,05% 19,75% 121.300
24/10/1997 10,63 10,75 10,38 10,50 +0,00% 3,53% 53.300
23/10/1997 11,00 11,00 10,38 10,50 -5,62% 5,68% 53.800
22/10/1997 11,13 11,25 10,88 11,13 +0,00% 3,37% 77.300
21/10/1997 11,00 11,44 11,00 11,13 +0,56% 3,98% 220.700
20/10/1997 11,00 11,38 10,81 11,06 +1,72% 5,11% 51.600
17/10/1997 10,75 10,88 10,38 10,88 +0,00% 4,65% 53.000
16/10/1997 11,38 11,38 10,88 10,88 -3,33% 4,40% 40.600
15/10/1997 11,38 11,63 11,13 11,25 -2,17% 4,40% 90.100
14/10/1997 11,63 11,88 11,38 11,50 -0,54% 4,30% 117.100
13/10/1997 11,25 11,75 11,25 11,56 +2,21% 4,44% 234.800
10/10/1997 11,25 11,44 11,00 11,31 +0,56% 3,89% 216.600
09/10/1997 11,25 11,88 10,75 11,25 +2,27% 10,00% 172.600
08/10/1997 10,75 11,63 10,75 11,00 +3,53% 8,14% 499.200
07/10/1997 10,25 10,88 10,13 10,63 +3,66% 7,32% 276.800
06/10/1997 9,88 10,50 9,81 10,25 +6,49% 6,96% 84.800
03/10/1997 10,00 10,13 9,63 9,63 -4,94% 5,00% 47.800
02/10/1997 9,50 10,13 9,50 10,13 +6,58% 6,58% 74.100
01/10/1997 9,56 9,81 9,13 9,50 -0,65% 7,19% 120.800
30/09/1997 9,69 9,88 9,56 9,56 -1,92% 3,23% 160.600
29/09/1997 10,19 10,19 9,75 9,75 -3,70% 4,29% 76.400